2003
The Role of Medicaid HMO Enrollment in the Longitudinal Utilization of Medical Care Services in a Cohort of Injecting Drug users in Baltimore, Maryland
Juday T, Wu A, Celentano D, Rick K, Wang M, Vlahov D. The Role of Medicaid HMO Enrollment in the Longitudinal Utilization of Medical Care Services in a Cohort of Injecting Drug users in Baltimore, Maryland. Substance Use & Addiction Journal 2003, 24: 27-41. PMID: 12652093, DOI: 10.1080/08897070309511531.Peer-Reviewed Original ResearchConceptsAmbulatory care visitsCare visitsInpatient admissionsHMO enrollmentDrug usersMedicaid HMO enrolleesMore inpatient admissionsInjecting Drug UsersMedical care utilizationNatural history studiesIntravenous Experience (ALIVE) studyMedical care servicesCommunity-based sampleLongitudinal utilizationER visitsHIV infectionCare utilizationMedicaid beneficiariesHMO enrolleesCare servicesIDUsInappropriate utilizationUtilization differencesMedicaidMedicaid HMOsFactors Associated With Human Herpesvirus Type 8 Infection in an Injecting Drug User Cohort
Bernstein K, Jacobson L, Jenkins F, Vlahov D, Armenian H. Factors Associated With Human Herpesvirus Type 8 Infection in an Injecting Drug User Cohort. Sexually Transmitted Diseases 2003, 30: 199-204. PMID: 12616135, DOI: 10.1097/00007435-200303000-00004.Peer-Reviewed Original ResearchConceptsHHV-8 seroprevalenceRisk factorsHHV-8Human herpesvirus type 8 infectionLarger body mass indexHuman herpesvirus type 8Drug user cohortHHV-8 seropositivityInjection drug useBody mass indexMultivariate logistic regressionCross-sectional studyDrug user populationGenital wartsMass indexGeneral populationDrug useSeroprevalenceIndirect immunofluorescenceLogistic regressionIDUsInfectionType 8User cohortSexual behavior
2001
Injecting misuse of buprenorphine among French drug users
Obadia Y, Perrin V, Feroni I, Vlahov D, Moatti J. Injecting misuse of buprenorphine among French drug users. Addiction 2001, 96: 267-272. PMID: 11182872, DOI: 10.1046/j.1360-0443.2001.96226710.x.Peer-Reviewed Original ResearchConceptsDrug maintenance treatmentSample of IDUsNeedle exchange programsDrug usersMisuse of buprenorphineCross-sectional surveySelf-administered questionnaireAmbulatory prescriptionsMaintenance treatmentAmbulatory careCommunity pharmaciesBuprenorphineSterile syringesSubstantial riskIDUsLatter groupIllicit usePolydrug usersHIVExchange programsMonthsRisky behaviorsPrescriptionPharmacyMisuse
1999
New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug users
Krol A, Flynn C, Vlahov D, Miedema F, Coutinho R, van Ameijden E. New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug users. Drug And Alcohol Dependence 1999, 54: 145-154. PMID: 10217554, DOI: 10.1016/s0376-8716(98)00158-6.Peer-Reviewed Original Research
1998
Satellite exchange in the Baltimore Needle Exchange Program.
Valente T, Foreman R, Junge B, Vlahov D. Satellite exchange in the Baltimore Needle Exchange Program. Public Health Reports 1998, 113 Suppl 1: 90-6. PMID: 9722814, PMCID: PMC1307731.Peer-Reviewed Original ResearchConceptsPrevention messagesBaltimore Needle Exchange ProgramHIV prevention messagesNeedle exchange programsNeedle exchange program participantsDrug-using networksDrug injectorsNumber of syringesDrug usersDrug useRisk behaviorsLogistic regressionOne-way ANOVAIDUsPrevention materialsProgram effectivenessProgram participantsActivities of SSParticipantsPotential bridgeExchange programs
1997
Persistence and Clinical Significance of Hepatitis G Virus Infections in Injecting Drug Users
Thomas D, Nakatsuji Y, Shih J, Alter H, Nelson K, Astemborski J, Lyles C, Vlahov D. Persistence and Clinical Significance of Hepatitis G Virus Infections in Injecting Drug Users. The Journal Of Infectious Diseases 1997, 176: 586-592. PMID: 9291303, DOI: 10.1086/514078.Peer-Reviewed Original ResearchConceptsHepatitis G virus infectionG virus infectionHGV RNAHGV infectionVirus infectionDrug usersLiver-related enzymesRecent serum sampleInjecting Drug UsersHepatic inflammationAcute infectionSerum levelsLiver diseaseClinical significanceNegative participantsSerial samplesDrug useInfectionPrior visitSerum samplesIDUsPrior specimensRecent visitVisitsYearsSyphilis in injecting drug users: clues for high-risk sexual behaviour in female IDUs
Muga R, Roca J, Tor J, Pigem C, Rodriguez R, Egea J, Vlahov D, Muñoz A. Syphilis in injecting drug users: clues for high-risk sexual behaviour in female IDUs. International Journal Of STD & AIDS 1997, 8: 225-228. PMID: 9147154, DOI: 10.1258/0956462971919967.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusRapid plasma reagentEnzyme-linked immunosorbent assaySerologic syphilisDrug usersSex partnersHigh-risk sexual behaviorCross-sectional analysisGender-specific differencesMale IDUsHIV infectionImmunodeficiency virusFemale IDUsSexual transmissionTreponemal testsReactive samplesSyphilisSexual partnersWestern blotImmunosorbent assayIDUsPlasma reagentWomenSexual behaviorMenA Morphine Prescription Program in Italy (1980-1985): Retrospective Evidence of Protection Against Hiv/Aids
Sagliocca L, Rezza G, Vlahov D, Baldassarre C, Siconolfi M, Nespoli M, Carriers P. A Morphine Prescription Program in Italy (1980-1985): Retrospective Evidence of Protection Against Hiv/Aids. Addiction Research & Theory 1997, 5: 137-144. DOI: 10.3109/16066359709005255.Peer-Reviewed Original ResearchLow HIV prevalence rateHIV-negative IDUsHIV-negative controlsCase-control studyDrug treatment centersSterile injection equipmentHIV prevalence ratesInsufficient dosesHIV infectionPrescription programPrevalence ratesAlternative treatmentTreatment centersDrug usersHIV/AidsRetrospective evidenceMorphineMethadoneInfectionInjection equipmentHIVIDUsDoses
1995
Incidence and Risk Factors for Human T-Lymphotropic Virus Type II Seroconversion Among Injecting Drug Users in Baltimore, Maryland, U.S.A
Vlahov D, Khabbaz R, Cohn S, Galai N, Taylor E, Kaplan J. Incidence and Risk Factors for Human T-Lymphotropic Virus Type II Seroconversion Among Injecting Drug Users in Baltimore, Maryland, U.S.A. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1995, 9: 89-96. PMID: 7712239, DOI: 10.1097/00042560-199505010-00013.Peer-Reviewed Original ResearchConceptsRisk factorsDrug usersEnzyme immunoassayWestern blotHuman T-lymphotropic virusNeedle-sharing practicesRisk factor analysisT-lymphotropic virusMedian lag timeCase-control designALIVE studyRecent serumSeronegative IDUsStudy entryBaseline historyIncidence rateSeroconversionPositive casesSex partnersIDUsHTLVCalendar timeMonthsIncidenceBaseline
1994
Changes in HIV Risk Behaviors among Counseled Injecting Drug Users
Mandell W, Vlahov D, Latkin C, Carran D, Oziemkowska M, Reedt L. Changes in HIV Risk Behaviors among Counseled Injecting Drug Users. Journal Of Drug Issues 1994, 24: 555-567. DOI: 10.1177/002204269402400314.Peer-Reviewed Original ResearchHIV risk behaviorsRisk behaviorsShort-term educational interventionHIV-seronegative IDUsEducational interventionInjecting Drug UsersIntensive educational interventionSeronegative IDUsHIV infectionSignificant additional benefitSix monthsDrug usersDrug useEducational sessionsIntensive interventionReduction of activityOne hourInterventionIDUsCommunity sampleFifteen minutesInjection equipmentMonthsRisky behaviorsAdditional benefit